Imricor Medical Systems, Inc. announced it has received a grant award of USD 1.158 million from the North Dakota Department of Agriculture as part of the department's Bioscience Innovation Grant (BIG) program. The grant funds will support the Company's remaining US approval process, including the VISABL-AFL clinical trial and the subsequent FDA review.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.455 AUD | 0.00% | -3.19% | -20.18% |
09/05 | Imricor Medical Systems' VISABL-AFL Trial Receives Final Clearance from Swissmedic | MT |
02/05 | Imricor Medical Systems Announces Release of Certain Stocks from Voluntary Escrow | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.18% | 60.85M | |
+11.29% | 226B | |
+8.76% | 188B | |
+12.90% | 137B | |
+25.95% | 108B | |
+0.34% | 63.19B | |
+11.08% | 52.26B | |
+5.62% | 51B | |
+6.28% | 43.89B | |
+4.80% | 38.07B |
- Stock Market
- Equities
- IMR Stock
- News Imricor Medical Systems, Inc.
- Imricor Medical Systems, Inc. Receives USD 1.158 Million Grant